Axxam announces appointment of Ciriaco Maraschiello as Chief Executive Officer Leave a Comment / News / ASolia 10 January 2025 Axxam announces appointment of Ciriaco Maraschiello as Chief Executive Officer Read More »
Axxam S.p.A. accelerates global expansion incorporating Axxam Inc. Leave a Comment / News / ASolia 10 October 2024 – 14:00 CEST Axxam S.p.A. accelerates global expansion incorporating Axxam Inc. Read More »
Axxam adopts CDD Vault to enhance early drug discovery services Leave a Comment / News / ASolia 10 October 2024 – 14:00 CEST Axxam adopts CDD Vault to enhance early drug discovery services Read More »
Opertech Bio and AXXSense Enter Strategic Cooperation Agreement Leave a Comment / News / ASolia 10 October 2024 – 14:00 CEST Opertech Bio and AXXSense Enter Strategic Cooperation Agreement Read More »
Isogenica Ltd. and Axxam S.p.A. Announce Collaboration to Provide Unique VHH Antibody Discovery Solutions Leave a Comment / News / ASolia Example single news Isogenica Ltd. and Axxam S.p.A. Announce Collaboration to Provide Unique VHH Antibody Discovery Solutions Read More »
Axxam Awarded EcoVadis Silver Medal for Sustainability Performance Leave a Comment / News / ASolia Example single news Axxam Awarded EcoVadis Silver Medal for Sustainability Performance Read More »
Axxam enters CNS partnership with Lundbeck for Lead Identification Leave a Comment / News / ASolia Example single news Axxam enters CNS partnership with Lundbeck for Lead Identification Read More »
Momentum Biotechnologies and Axxam announce collaboration to provide unique drug discovery solutions Leave a Comment / News / ASolia Example single news Momentum Biotechnologies and Axxam announce collaboration to provide unique drug discovery solutions Read More »
Ciriaco Maraschiello joins Axxam as Chief Operating Officer Leave a Comment / News / ASolia 5 July 2023 Ciriaco Maraschiello joins Axxam as Chief Operating Officer Read More »
Uwe Gottschalk appointed as Board Observer Leave a Comment / News / ASolia 15 June 2023 Uwe Gottschalk appointed as Board Observer Read More »